Thomas Nick, Vaidya Bijay, Leslie Richard David, Agardh Daniel, Oram Richard, Dabelea Dana, Singh Arunjot, Chantzichristos Dimitrios, Rewers Marian
Institute of Biomedical and Clinical Science, University of Exeter Medical School, Devon, UK.
Department of Endocrinology, Royal Devon and Exeter Hospital, University of Exeter Medical School, Exeter, UK.
Diabetes Metab Res Rev. 2026 Jan;42(1):e70110. doi: 10.1002/dmrr.70110.
Timely diagnosis of type 1 diabetes (T1D), especially in high-risk populations, is crucial for preventing serious health complications. T1D is a chronic progressive autoimmune disease that has presymptomatic stages that can be identified through the detection of islet autoantibodies. Given that T1D is associated with other autoimmune diseases, having either those diseases or a family history of them will represent a risk of T1D. From a search of the literature conducted in August 2024, we review here the evidence for the risk of either T1D or the development of T1D in association with other autoimmune diseases or a family history of those diseases. Increased risk of subsequent T1D development was identified for individuals with autoimmune diseases, including coeliac disease, autoimmune thyroid disease, autoimmune Addison's disease, juvenile idiopathic arthritis, primary biliary cholangitis, ulcerative colitis, vitiligo, and myasthenia gravis. Increased prevalence of diabetes-associated autoantibody positivity was found among non-diabetic individuals with coeliac and autoimmune thyroid diseases compared with individuals without these autoimmune diseases. Increased risk of T1D was also found for individuals with a family history of autoimmune diseases, including coeliac disease, thyroid disease, Addison's disease, rheumatoid arthritis, systemic lupus erythematosus, Sjögren's syndrome, autoimmune liver disease, pernicious anaemia, inflammatory bowel disease, multiple sclerosis, and granulomatosis with polyangiitis. This review highlights how certain individuals at risk of T1D can be identified to offer them islet autoantibody screening and, thereby, early detection of T1D.
1型糖尿病(T1D)的及时诊断,尤其是在高危人群中,对于预防严重的健康并发症至关重要。T1D是一种慢性进行性自身免疫性疾病,有症状前阶段,可通过检测胰岛自身抗体来识别。鉴于T1D与其他自身免疫性疾病有关,患有这些疾病或有其家族病史将代表患T1D的风险。通过对2024年8月进行的文献检索,我们在此回顾与其他自身免疫性疾病或这些疾病的家族病史相关的T1D风险或T1D发生的证据。已确定患有自身免疫性疾病的个体,包括乳糜泻、自身免疫性甲状腺疾病、自身免疫性艾迪生病、幼年特发性关节炎、原发性胆汁性胆管炎、溃疡性结肠炎、白癜风和重症肌无力,后续发生T1D的风险增加。与没有这些自身免疫性疾病的个体相比,患有乳糜泻和自身免疫性甲状腺疾病的非糖尿病个体中糖尿病相关自身抗体阳性的患病率更高。有自身免疫性疾病家族病史的个体,包括乳糜泻、甲状腺疾病、艾迪生病、类风湿关节炎、系统性红斑狼疮、干燥综合征、自身免疫性肝病、恶性贫血、炎症性肠病、多发性硬化症和显微镜下多血管炎,患T1D的风险也增加。本综述强调了如何识别某些有T1D风险的个体,为他们提供胰岛自身抗体筛查,从而早期发现T1D。